Comparison of HE4, CA125, and Risk of Ovarian Malignancy Algorithm in the Prediction of Ovarian Cancer in Korean Women.
10.3346/jkms.2015.30.12.1777
- Author:
Hye Yon CHO
1
;
Sung Ho PARK
;
Young Han PARK
;
Hong Bae KIM
;
Jung Bae KANG
;
Seung Hwa HONG
;
Min Sun KYUNG
Author Information
1. Department of Obstetrics & Gynecology, Hallym University Medical Center, Hwaseong, Korea. msfeel@hallym.or.kr
- Publication Type:Clinical Study ; Comparative Study ; Original Article ; Multicenter Study ; Research Support, Non-U.S. Gov't
- Keywords:
CA125 Antigen;
HE4;
ROMA;
Tumor Markers, Biological;
Ovarian Neoplasms
- MeSH:
Algorithms;
Area Under Curve;
Biomarkers, Tumor/blood;
CA-125 Antigen/*blood;
Case-Control Studies;
Female;
Humans;
Middle Aged;
Neoplasms, Glandular and Epithelial/*blood/*diagnosis;
Ovarian Neoplasms/*blood/*diagnosis;
Predictive Value of Tests;
Prospective Studies;
Proteins/*metabolism;
ROC Curve;
Reference Values;
Republic of Korea
- From:Journal of Korean Medical Science
2015;30(12):1777-1783
- CountryRepublic of Korea
- Language:English
-
Abstract:
This study is a multi-center clinical study, which aimed to compare CA125, HE4, and risk of ovarian malignancy algorithm (ROMA) in predicting epithelial ovarian cancer of Korean women with a pelvic mass. Prospectively, serum from 90 Korean women with ovarian mass was obtained prior to surgery. For control group, serum from 79 normal populations without ovarian mass was also obtained. The HE4 and CA125 data were registered and evaluated separately and ROMA was calculated for each sample. Total 67 benign tumors and 23 ovarian cancers were evaluated. Median serum levels of HE4 and CA125, and ROMA score were significantly higher in patients with ovarian cancer than those with benign ovarian tumor and normal population (P < 0.001). In ROC curve analysis for women with a pelvic mass, area under the curve (AUC) for HE4 and ROMA was higher than CA125. Statistical differences in each study compared to CA125 were marginal (P compared to CA125; 0.082 for HE4 and 0.069 for ROMA). Sub-analysis revealed that AUC for HE4 and ROMA was higher than AUC for CA125 in post-menopausal women with a pelvic mass, but there were no statistically significant differences (P compared to CA125; 0.160 for HE4 and 0.127 for ROMA). Our data suggested that both HE4 and ROMA score showed better performance than CA125 for the detection of ovarian cancer in women with a pelvic mass. HE4 and ROMA can be a useful independent diagnostic marker for epithelial ovarian cancer in Korean women.
